It Took 7 Miscarriages, 10 IVF cycles, 9 Years, and Nearly $200,000 to Solve My Fertility Issues
By Elizabeth Katkin,
Marie Claire
| 06. 15. 2018
After six miscarriages, six fresh in vitro fertilization (IVF) cycles, two frozen IVF cycles, and one healthy not yet two-year-old daughter, I was told by my New York–based fertility specialist and embryologist to give up on having another genetic child. I had just turned 40. Though I had spent nearly $200,000 on fertility treatments in the U.S. and the U.K.—a staggering sum—my previous two IVF cycles had produced precisely zero useable embryos. The seasoned professionals at my clinic in New York gently told me that it was time to face facts: I likely had no good eggs left. Experts I had seen over the previous eight years echoed their opinion.
Throughout the course of my fertility journey, I had been “blessed” with the ability to produce lots of eggs. The IVF cycle that brought us our daughter had been no different than its predecessors: twenty-eight eggs retrieved, seventeen fertilized, and thirteen mature embryos on the third day of their existence—science-speak for a reassuringly ample supply. But genetic testing revealed a startling result: only three of our embryos were chromosomally normal...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...